Close
Nordic 9Nordic 9

Amgen (investor - Corporate Investor)

United States
See something wrong or missing? Let us know
Offices:San Francisco
Average round investment:527M USD
Average number per year:3.0
Distribution: 2025 (3)
Portfolio companies: United Kingdom Dark Blue TherapeuticsItaly AAVantgarde BioUnited Kingdom Quantinuum
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Amgen

Name Criteria
United States Rock Springs Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Perceptive Advisors
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Blue Owl Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Sweden Nordic Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United Kingdom Baillie Gifford
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Italy
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Sweden Scania Growth Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany Porsche
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France Korelya Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
United States Bill & Melinda Gates Foundation Trust
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Singapore nVentures
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top